The Diabcare-Asia 1998 Study -Outcomes on Control and Complications in Type 1 and Type 2 Diabetic Patients

Nitiyanant, Wannee; Tandhanand, S; Mahtab, Hajera; Zhang, Xiaoming; Pan, Changyu; Raheja, Bihari S; Sathe, Sonal; Soegondo, Sidartawan; Soewondo, Pradana; Kim, Y. S.; Embong, Mustaffa; Lantion-Ang, Lina C.; Lim-Abraham, M.; Lee, W. W.R.; Wijesuriya, Mahen; Tai, Tong-Yuan; Chuang, Lee‐Ming; Le, Hqe; Cockram, Clive S.; Jørgensen, Lars N.; Yeo, Jing Ping

doi:10.1185/030079902125000822

Cited by 29 publications

(24 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, the mean age at onset was 13.6 years among 49 027 T1D patients followed by the German Diabetes Documentation System, whereas the T1D Exchange study, which has followed thousands of patients in the US, reported a median age at diagnosis of 9.0 years . Nonetheless, comparing the characteristics of patients with T1D in the present study with those in the Diab‐care Asia study, an observational study performed in 230 diabetic centers in 12 Asian regions, shows similarities in the age at onset (27.5 vs 29.2, respectively) and in the peak onset age groups (between 20–29 years in both studies). In the present study, disease onset was after 20 years of age in 69.9% of patients.…”

Section: Discussionmentioning

confidence: 99%

Demographic and clinical characteristics of patients with type 1 diabetes mellitus: A multicenter registry study in Guangdong, China

Yang

Deng

Luo

et al. 2016

Journal of Diabetes

View full text Add to dashboard Cite

The adult-onset form of T1D is not rare in China. The registry participants were characterized by older age at onset, lower BMI, and a higher prevalence of DKA at onset compared with those in regions with a high incidence of T1D, such as northern Europe. These findings contribute to a better understanding of the heterogeneity of T1D in different populations and so will help healthcare providers to develop management models that are more suitable for these patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Demographic and clinical characteristics of patients with type 1 diabetes mellitus: A multicenter registry study in Guangdong, China

Yang

Deng

Luo

et al. 2016

Journal of Diabetes

View full text Add to dashboard Cite

show abstract

“…The average HbA1c levels in other countries have been reported to range from 7.5% to 8.6% (17)(18)(19)(20)(21)(22)(23)(24)(25). However, glycemic control in Asian patients with DM is generally poor (23)(24)(25), whereas the average level of glycemic control in Japan is fair (2,3). One study (2) reported that the mean HbA1c level in 16,934 Japanese patients with DM in 2002 was 7.5%, while another study (3) showed that the mean HbA1c level in 15,652 Japanese DM patients in 2006 was 7.2%.…”

Section: Discussionmentioning

confidence: 99%

Status of Diabetes Treatment in Japanese Adults: An Analysis of the 2009 Japan Society of Ningen Dock Database

2014

View full text Add to dashboard Cite

Objective The Japan Diabetes Society (JDS) has recommended target levels of glycemic control based on guidelines for the management of diabetes mellitus (DM). The Japan Society of Ningen Dock created a database of subjects receiving annual health examinations nationwide. Using this database, we evaluated the efficacy of current treatment for patients with DM based on the JDS recommendations. Methods This multicenter, retrospective study was conducted using data obtained from 21 institutions across Japan. In order to assess the level of glycemic control in the Japanese population, we analyzed previously obtained measurements of HbA1c in 7,180 patients 20 to 79 years of age (mean age: 57.9±8.7 years, 6,007 men and 1,173 women) taking DM medications. Results According to the JDS guidelines, 44.7% of the patients fell into the good glycemic control group, with an HbA1c level of <7.0% while 22.4% were classified into the poor glycemic control group, with an HbA1c level of ! 8.0%. The control of other arteriosclerosis risk factors deteriorated as the glycemic control deteriorated. Lifestyle factors were strongly found to be associated with glycemic control in the patients receiving DM treatment. Conclusion Aggressive lifestyle modification is needed to improve glycemic control in patients with DM.

show abstract

“…This project was initiated in 1997 in 6 countries and subsequently extended to 11 countries in 1998. [7] In 2001, DiabCare India was first published which involved patients from primary health care sectors,[8] and in 2003, DiabCare Asia collected information of patients managed by specialist's care. [9] DiabCare India 2011 was initiated with the aim to evaluate the current Status of diabetes management, its control and complication ten years after the completion of the last DiabCare study in India.…”

Section: Introductionmentioning

confidence: 99%

Current status of management, control, complications and psychosocial aspects of patients with diabetes in India: Results from the DiabCare India 2011 Study

Mohan

Shah

Joshi

et al. 2014

Indian J Endocr Metab

View full text Add to dashboard Cite

Objectives:DiabCare India 2011 was a cross-sectional study in patients with diabetes mellitus, undertaken to investigate the relationship between diabetes control, management and complications in a subset of urban Indian diabetes patients treated at referral diabetes care centres in India.Materials and Methods:This was a cross-sectional, multicentre (330 centres) survey in 6168 diabetes patients treated at general hospitals, diabetes clinics and referral clinics across India. Patient data, including medical and clinical examination reports during the past year were collected during their routine visit. The patients’ and physicians’ perceptions about diabetes management were recorded using a questionnaire.Results:A total of 6168 subjects with diabetes (95.8% type 2), mean age 51.9 ± 12.4 years and mean duration of diabetes, 6.9 ± 6.4 years were included. Mean HbA1c was 8.9 ± 2.1% and the mean fasting (FPG), post prandial (PPG) and random (RBG) plasma glucose levels were 148 ± 50 mg/dl 205 ± 66 mg/dl and 193 ± 68mg/dl respectively. Neuropathy was the most common complication (41.4%); other complications were: Foot (32.7%), eye (19.7%), cardiovascular (6.8%) and nephropathy (6.2%). The number of diabetic complications increased with mean duration of diabetes. Most (93.2%) of the patients were on oral anti-diabetic drugs (OADs) and 35.2% were on insulin (±OADs). More than 15% physicians felt that the greatest barrier to insulin therapy from patient's perspective were pain and fear of using injectable modality; 5.2% felt that the greatest barrier to insulin therapy from physician's perspective was the treatment cost; 4.8% felt that the major barriers to achieve optimum diabetic care in practice was loss to follow-up followed by lack of counselling (3.9%) and treatment compliance (3.6%).Conclusion:DiabCare India 2011 has shown that type 2 diabetes sets in early in Indians and glycaemic control is often sub-optimal in these patients. These results indicate a need for more structured intervention at an early stage of the disease and need for increased awareness on benefits of good glycaemic control. It cannot be overemphasized that the status of diabetes care in India needs to be further improved. (ClinTrials.gov identifier: NCT01351922)

show abstract

The Diabcare-Asia 1998 Study -Outcomes on Control and Complications in Type 1 and Type 2 Diabetic Patients

Abstract: The Inadequate metabolic and hypertension control, especially in type 2 patients, needs to be addressed.

Cited by 29 publications

References 29 publications

Demographic and clinical characteristics of patients with type 1 diabetes mellitus: A multicenter registry study in Guangdong, China

Demographic and clinical characteristics of patients with type 1 diabetes mellitus: A multicenter registry study in Guangdong, China

Status of Diabetes Treatment in Japanese Adults: An Analysis of the 2009 Japan Society of Ningen Dock Database

Current status of management, control, complications and psychosocial aspects of patients with diabetes in India: Results from the DiabCare India 2011 Study

Contact Info

Product

Resources

About